Dabigatran for stroke prevention in all patients with atrial fibrillation?

Pharmacotherapy. 2011 Aug;31(8):725-8. doi: 10.1592/phco.31.8.725.
No abstract available

Publication types

  • Case Reports
  • Editorial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use*
  • Dabigatran
  • Drug Monitoring / methods
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Stroke / etiology
  • Stroke / prevention & control*
  • Warfarin / adverse effects
  • Warfarin / therapeutic use
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Warfarin
  • Dabigatran